Esperion Therapeutis.Inc. buy Global_Player
Start price
07.12.22
/
50%
€6.49
Target price
07.12.23
-
Performance (%)
-26.62%
End price
11.12.22
€4.76
Summary
This prediction ended on 11.12.22 with a price of €4.76. The prediction for Esperion Therapeutis.Inc. disappointed with a performance of -26.62%. Global_Player has a follow-up prediction for Esperion Therapeutis.Inc. where he still thinks Esperion Therapeutis.Inc. is a Buy. Global_Player has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Esperion Therapeutis.Inc. | -2.985% | -2.985% | 60.753% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
Comments by Global_Player for this prediction
In the thread Esperion Therapeutis.Inc. diskutieren
Buy Esperion Therapeutis.Inc.
In the thread Trading Esperion Therapeutis.Inc.
Current prediction by Global_Player for Esperion Therapeutis.Inc.
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.85
25.04.24
25.04.24
-
25.04.25
25.04.25
-4.27%
26.04.24
26.04.24
Stopped prediction by Global_Player for Esperion Therapeutis.Inc.
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.39
28.08.23
28.08.23
-
28.08.24
28.08.24
5.04%
30.08.23
30.08.23
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€13.02
26.07.21
26.07.21
-
26.07.22
26.07.22
-6.99%
08.08.21
08.08.21